A partnership agreement has been established between Abionic and Genentech

We are pleased to share some positive news on our BOV I and BOV II portfolio company Abionic

Last week, the official announcement of a partnership agreement between Abionic and Genentech was released.

Genentech is part of the Roche pharmaceutical group and the commercial entity for Roche in the USA.